Orion Minerals (ORN) Investor Update summary

Scientific and operational milestones

• Achieved 60% GLA expression in GLASO safflower seeds, surpassing expectations and improving oil yield.

• Received USDA APHIS regulatory clearance for GLA-producing safflower, completing the U.S. regulatory pathway.

• Scaled up prototyping operations from 3 to 300 liters, confirming transgenic events in seeds.

• Advanced soybean and pea projects to key development stages, confirming gene integration and expression.

• Expanded safflower seed multiplication by 42x for SBC2 and 25x for GLASO, enhancing production capacity.

Integration and strategic partnerships

• Acquired a fully operational soybean processing facility with 10,000 tons/year capacity.

• Signed MOU with Bioceres Crop Solutions for up to 20,000 tons of HB4 soybeans over three years.

• HB4 soybeans offer drought tolerance, traceability, and sustainability benefits.

• Partnership supports ESG goals, including carbon neutrality and transparent value chains.

Business plan and market opportunity

• Total addressable market for 2025 estimated at $827 billion, with a $37 billion serviceable market.

• Focused on TVP, GLA, and chymosin markets, driven by alternative protein industry growth.

• Business plan includes four stages, progressing from traditional soy processing to molecular farming-enabled products.

• Asset-light approach with a global network of customers and sustainable procurement.